Low level laser therapy versus pharmacotherapy in improving myofascial pain disorder syndrome

ABSTRACT

Introduction: Temporomandibular disorders [TMD] lead to masticatory muscle pain, jaw movement disability and limitation in mouth opening. Pain is the chief complaint in 90% of the TMD patients which leads to disability and severe socioeconomic costs. The purpose of this study was to evaluate the therapeutic effects of low level laser therapy [LLLT] compared to pharmacotherapy with NSAIDs [naproxen] in myofascial pain disorder syndrome [MPDS]